Rupesh Jain
Impact in
-
- Advancements in Transdermal Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 4
- Co-authors
- Gautam Singhvi (9 shared papers)Sunil Kumar Dubey (9 shared papers)Madhuri Kanitkar (2 shared papers)Prem Pais (1 shared paper)Padmini Devi (1 shared paper)Arvind Bagga (2 shared papers)Natarajan Chidambaram (1 shared paper)Prafulla Kerkar (1 shared paper)
- Journals
- International Journal of Biological Macromolecules (1 paper)Pharmaceutics (1 paper)Molecular Pharmaceutics (1 paper)Current Drug Delivery (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- IndiaUnited Arab Emirates
In The Last Decade
Rupesh Jain
13 papers receiving 289 citations
Peers
Comparison fields: 5 of 73
- Pharmaceutical Science 24
- Dermatology 24
- Biomaterials 34
- Cardiology and Cardiovascular Medicine 50
- Molecular Medicine 12
Countries citing papers authored by Rupesh Jain
This map shows the geographic impact of Rupesh Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupesh Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupesh Jain more than expected).
Fields of papers citing papers by Rupesh Jain
This network shows the impact of papers produced by Rupesh Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupesh Jain. The network helps show where Rupesh Jain may publish in the future.
Co-authors
The 25 scholars most cited alongside Rupesh Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 102 | |
| 2 | 2021 | 32 | |
| 3 | Evaluation and management of hypertension. | 2007 | 28 |
| 4 | 2023 | 25 | |
| 5 | 2024 | 24 | |
| 6 | 2020 | 22 | |
| 7 | 2020 | 18 | |
| 8 | 2022 | 16 | |
| 9 | 2020 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2023 | 8 | |
| 12 | 2019 | 6 | |
| 13 | Evaluation and management of Hypertension :44:103-21 | 2007 | 4 |
About Rupesh Jain
Rupesh Jain is a scholar working on Biomedical Engineering, Molecular Biology, Pulmonary and Respiratory Medicine, Pharmaceutical Science and Dermatology, having authored 13 papers that have together received 302 indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (4 papers), Nanoplatforms for cancer theranostics (4 papers), Sodium Intake and Health (2 papers), Blood Pressure and Hypertension Studies (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Skin Protection and Aging (2 papers), Genetic and rare skin diseases. (1 paper) and Porphyrin and Phthalocyanine Chemistry (1 paper). The work is most often cited by research in Pharmaceutical Science (24 citations), Dermatology (24 citations), Biomaterials (34 citations), Cardiology and Cardiovascular Medicine (50 citations) and Molecular Medicine (12 citations). Rupesh Jain has collaborated with scholars based in India and United Arab Emirates. Frequent co-authors include Gautam Singhvi, Sunil Kumar Dubey, Madhuri Kanitkar, Prem Pais, Padmini Devi, Arvind Bagga, Natarajan Chidambaram, Prafulla Kerkar, Uma Ali and Alben Sigamani. Their work appears in journals such as International Journal of Biological Macromolecules, Pharmaceutics, Molecular Pharmaceutics, Current Drug Delivery and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.